abstract |
This invention is directed to a compound wherein R<1,> R<2>, R<3>, R<4> and L<1> are as defined herein, a pharmaceutical composition comprising the compound, and the use of the compound to treat allergic and/or inflammatory disorders, particularly disorders such as allergic rhinitis, asthma and/or chronic obstructive pulmonary disease (COPD). |